Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, Canada.

IF 1.3 4区 医学 Q4 HEALTH CARE SCIENCES & SERVICES Journal of Palliative Care Pub Date : 2023-04-01 DOI:10.1177/08258597211072946
Shaila J Merchant, Weidong Kong, Aamer Mahmud, Christopher M Booth, Timothy P Hanna
{"title":"Palliative Radiotherapy for Esophageal and Gastric Cancer: Population-Based Patterns of Utilization and Outcomes in Ontario, Canada.","authors":"Shaila J Merchant,&nbsp;Weidong Kong,&nbsp;Aamer Mahmud,&nbsp;Christopher M Booth,&nbsp;Timothy P Hanna","doi":"10.1177/08258597211072946","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Patients with incurable esophageal and gastric cancer may develop local symptoms for which palliative radiotherapy (PRT) may be considered. We sought to evaluate patterns in utilization and outcomes of patients receiving PRT for incurable esophageal and gastric cancer in Ontario, Canada using health administrative data.</p><p><strong>Methods: </strong>Linked health administrative databases were used to identify patients receiving PRT for incurable esophageal and gastric cancer. Primary outcomes were utilization and delivery of PRT, utilization of endoscopic dilation with or without stent insertion after completion of PRT and survival from 1) date of diagnosis and 2) start of PRT.</p><p><strong>Results: </strong>We identified 2500 patients who received PRT. Mean age was 70 ± 13 years and the majority (75%, <i>n</i> = 1873/2500) were male. Over half of the patients had a diagnosis of gastric cancer (58%, <i>n</i> = 1453/2500) and began PRT within 6 months of cancer diagnosis (85%, <i>n</i> = 2125/2500). Of the 2500 patients in the cohort, 2174 patients received EBRT with few receiving brachytherapy (<i>n</i> = 326) or EBRT and brachytherapy combined (<i>n</i> = 88). Over the study period, there was an increase in the number of patients receiving PRT (136 in 2007 to 290 in 2016), as well as in the use of advanced conformal radiotherapy techniques. Only 5% (115/2500) required dilation with or without stent insertion after completion of PRT. Median overall and cancer-specific survival of the cohort was 205 days and 209 days from date of diagnosis and 108 days and 110 days from start of PRT.</p><p><strong>Conclusions: </strong>PRT is an important treatment for patients with incurable esophageal and gastric cancer who present with local symptoms. Utilization of PRT and advanced EBRT techniques increased over the study period. Few patients require endoscopic dilation with or without stent insertion after completion of PRT suggesting that PRT provides favorable symptom control.</p>","PeriodicalId":51096,"journal":{"name":"Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026159/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Palliative Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08258597211072946","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: Patients with incurable esophageal and gastric cancer may develop local symptoms for which palliative radiotherapy (PRT) may be considered. We sought to evaluate patterns in utilization and outcomes of patients receiving PRT for incurable esophageal and gastric cancer in Ontario, Canada using health administrative data.

Methods: Linked health administrative databases were used to identify patients receiving PRT for incurable esophageal and gastric cancer. Primary outcomes were utilization and delivery of PRT, utilization of endoscopic dilation with or without stent insertion after completion of PRT and survival from 1) date of diagnosis and 2) start of PRT.

Results: We identified 2500 patients who received PRT. Mean age was 70 ± 13 years and the majority (75%, n = 1873/2500) were male. Over half of the patients had a diagnosis of gastric cancer (58%, n = 1453/2500) and began PRT within 6 months of cancer diagnosis (85%, n = 2125/2500). Of the 2500 patients in the cohort, 2174 patients received EBRT with few receiving brachytherapy (n = 326) or EBRT and brachytherapy combined (n = 88). Over the study period, there was an increase in the number of patients receiving PRT (136 in 2007 to 290 in 2016), as well as in the use of advanced conformal radiotherapy techniques. Only 5% (115/2500) required dilation with or without stent insertion after completion of PRT. Median overall and cancer-specific survival of the cohort was 205 days and 209 days from date of diagnosis and 108 days and 110 days from start of PRT.

Conclusions: PRT is an important treatment for patients with incurable esophageal and gastric cancer who present with local symptoms. Utilization of PRT and advanced EBRT techniques increased over the study period. Few patients require endoscopic dilation with or without stent insertion after completion of PRT suggesting that PRT provides favorable symptom control.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
食管癌和胃癌的姑息放疗:基于人群的使用模式和结果在加拿大安大略省。
目的:无法治愈的食管癌和胃癌患者可能出现局部症状,可以考虑姑息性放疗(PRT)。我们试图利用卫生管理数据评估加拿大安大略省无法治愈的食管癌和胃癌患者接受PRT治疗的模式和结果。方法:使用相关的卫生管理数据库来识别接受PRT治疗的无法治愈的食管癌和胃癌患者。主要结局是PRT的使用和输送,PRT完成后内镜扩张伴或不伴支架植入的使用,以及从1)诊断日期和2)PRT开始的生存。结果:我们确定了2500例接受PRT治疗的患者。平均年龄70±13岁,男性居多(75%,n = 1873/2500)。超过一半的患者诊断为胃癌(58%,n = 1453/2500),并在癌症诊断后6个月内开始PRT (85%, n = 2125/2500)。在该队列的2500名患者中,2174名患者接受了EBRT,很少接受近距离治疗(n = 326)或EBRT和近距离治疗联合(n = 88)。在研究期间,接受PRT的患者数量有所增加(2007年为136人,2016年为290人),以及使用先进的适形放疗技术。只有5%(115/2500)的患者在PRT完成后需要扩张或不植入支架。队列的中位总生存期和癌症特异性生存期从诊断之日起分别为205天和209天,从PRT开始算起分别为108天和110天。结论:对于伴有局部症状的食管癌和胃癌患者,PRT是一种重要的治疗方法。在研究期间,PRT和先进EBRT技术的利用率有所增加。在PRT完成后,很少有患者需要内镜扩张或不植入支架,这表明PRT提供了良好的症状控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Palliative Care
Journal of Palliative Care 医学-卫生保健
CiteScore
3.20
自引率
5.90%
发文量
63
审稿时长
>12 weeks
期刊介绍: The Journal of Palliative Care is a quarterly, peer-reviewed, international and interdisciplinary forum for practical, critical thought on palliative care and palliative medicine. JPC publishes high-quality original research, opinion papers/commentaries, narrative and humanities works, case reports/case series, and reports on international activities and comparative palliative care.
期刊最新文献
EMPOWERING END-OF-LIFE CONVERSATIONS: The Role of Specialized Nursing Teams in Facilitating Code Status Changes at Discharge. Family Peace and Affecting Factors in Family Caregivers of Patients With Cancer: A Cross-Sectional Study. Electronic Patient Reported Outcomes Measures (e-PROMs) in Pediatric Palliative Oncology Care: A Scoping Review. A General Overview of Palliative Care in Morocco: Needs Far Beyond Means The Lived Experiences of Hospice Healthcare Workers Caring for Adolescents and Young Adults With Advanced Cancer: An Interpretative Phenomenological Analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1